Twins as Participants in Randomized Controlled Trials: A Review of Published Literature

Athula Sumathipala, Lisa Yelland, Debra Green, Tom Shepherd, Kaushalya Jayaweera, Paulo Ferreira, Jeffrey M. Craig

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Monozygotic (MZ) and dizygotic (DZ) twins participate in research that partitions variance in health, disease, and behavior into genetic and environmental components. However, there are other innovative roles for twins in medical research. One such way is involving MZ and/or DZ twins in co-twin control-designed randomized controlled trials (RCTs). To our knowledge, no reviews have been conducted that summarizes the involvement of twins in RCTs. Therefore, we conducted a systematic literature search using the U.S. Clinical Trials Database, NHS electronic databases, MEDLINE, EMBASE, and PsychINFO for RCTs on publications involving MZ and/or DZ twins as RCT participants. Out of the 186,027 clinical trials registered in the U.S. clinical trial register ClinicaTrails.gov, only six RCTs used twins as participants. From 1,598 articles identified in our search, 50 peer-reviewed English language publications met our pre-defined inclusion criteria. Sample sizes for RCTs have ranged from a total number of participants from 2 to 1,162; however, 32 (64%) studies had a sample size of 100 or less, and of those, 12 (24%) had fewer than 10. Both MZ and DZ twins have been recruited to the RCTs. In most instances (33/50) each twin from a pair were assigned to different study arms. Most of those studies included MZ twins only. Despite the methodological advantages, the use of MZ and DZ twins as participants in interventional RCTs appeared limited. The continuous development of innovative twin designs, especially RCTs, indicates that twin research can extend beyond the more widely recognized heritability estimates.

LanguageEnglish
Pages51-56
Number of pages6
JournalTwin Research and Human Genetics
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • RCT
  • randomization
  • sample size
  • twin research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology
  • Genetics(clinical)

Cite this

Sumathipala, A., Yelland, L., Green, D., Shepherd, T., Jayaweera, K., Ferreira, P., & Craig, J. M. (2018). Twins as Participants in Randomized Controlled Trials: A Review of Published Literature. Twin Research and Human Genetics, 21(1), 51-56. https://doi.org/10.1017/thg.2017.67
Sumathipala, Athula ; Yelland, Lisa ; Green, Debra ; Shepherd, Tom ; Jayaweera, Kaushalya ; Ferreira, Paulo ; Craig, Jeffrey M. / Twins as Participants in Randomized Controlled Trials : A Review of Published Literature. In: Twin Research and Human Genetics. 2018 ; Vol. 21, No. 1. pp. 51-56.
@article{574c68911cbe4c13a4df997122952e4b,
title = "Twins as Participants in Randomized Controlled Trials: A Review of Published Literature",
abstract = "Monozygotic (MZ) and dizygotic (DZ) twins participate in research that partitions variance in health, disease, and behavior into genetic and environmental components. However, there are other innovative roles for twins in medical research. One such way is involving MZ and/or DZ twins in co-twin control-designed randomized controlled trials (RCTs). To our knowledge, no reviews have been conducted that summarizes the involvement of twins in RCTs. Therefore, we conducted a systematic literature search using the U.S. Clinical Trials Database, NHS electronic databases, MEDLINE, EMBASE, and PsychINFO for RCTs on publications involving MZ and/or DZ twins as RCT participants. Out of the 186,027 clinical trials registered in the U.S. clinical trial register ClinicaTrails.gov, only six RCTs used twins as participants. From 1,598 articles identified in our search, 50 peer-reviewed English language publications met our pre-defined inclusion criteria. Sample sizes for RCTs have ranged from a total number of participants from 2 to 1,162; however, 32 (64{\%}) studies had a sample size of 100 or less, and of those, 12 (24{\%}) had fewer than 10. Both MZ and DZ twins have been recruited to the RCTs. In most instances (33/50) each twin from a pair were assigned to different study arms. Most of those studies included MZ twins only. Despite the methodological advantages, the use of MZ and DZ twins as participants in interventional RCTs appeared limited. The continuous development of innovative twin designs, especially RCTs, indicates that twin research can extend beyond the more widely recognized heritability estimates.",
keywords = "RCT, randomization, sample size, twin research",
author = "Athula Sumathipala and Lisa Yelland and Debra Green and Tom Shepherd and Kaushalya Jayaweera and Paulo Ferreira and Craig, {Jeffrey M.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1017/thg.2017.67",
language = "English",
volume = "21",
pages = "51--56",
journal = "Twin Research and Human Genetics",
issn = "1832-4274",
publisher = "Australian Academic Press",
number = "1",

}

Sumathipala, A, Yelland, L, Green, D, Shepherd, T, Jayaweera, K, Ferreira, P & Craig, JM 2018, 'Twins as Participants in Randomized Controlled Trials: A Review of Published Literature', Twin Research and Human Genetics, vol. 21, no. 1, pp. 51-56. https://doi.org/10.1017/thg.2017.67

Twins as Participants in Randomized Controlled Trials : A Review of Published Literature. / Sumathipala, Athula; Yelland, Lisa; Green, Debra; Shepherd, Tom; Jayaweera, Kaushalya; Ferreira, Paulo; Craig, Jeffrey M.

In: Twin Research and Human Genetics, Vol. 21, No. 1, 01.02.2018, p. 51-56.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Twins as Participants in Randomized Controlled Trials

T2 - Twin Research and Human Genetics

AU - Sumathipala, Athula

AU - Yelland, Lisa

AU - Green, Debra

AU - Shepherd, Tom

AU - Jayaweera, Kaushalya

AU - Ferreira, Paulo

AU - Craig, Jeffrey M.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Monozygotic (MZ) and dizygotic (DZ) twins participate in research that partitions variance in health, disease, and behavior into genetic and environmental components. However, there are other innovative roles for twins in medical research. One such way is involving MZ and/or DZ twins in co-twin control-designed randomized controlled trials (RCTs). To our knowledge, no reviews have been conducted that summarizes the involvement of twins in RCTs. Therefore, we conducted a systematic literature search using the U.S. Clinical Trials Database, NHS electronic databases, MEDLINE, EMBASE, and PsychINFO for RCTs on publications involving MZ and/or DZ twins as RCT participants. Out of the 186,027 clinical trials registered in the U.S. clinical trial register ClinicaTrails.gov, only six RCTs used twins as participants. From 1,598 articles identified in our search, 50 peer-reviewed English language publications met our pre-defined inclusion criteria. Sample sizes for RCTs have ranged from a total number of participants from 2 to 1,162; however, 32 (64%) studies had a sample size of 100 or less, and of those, 12 (24%) had fewer than 10. Both MZ and DZ twins have been recruited to the RCTs. In most instances (33/50) each twin from a pair were assigned to different study arms. Most of those studies included MZ twins only. Despite the methodological advantages, the use of MZ and DZ twins as participants in interventional RCTs appeared limited. The continuous development of innovative twin designs, especially RCTs, indicates that twin research can extend beyond the more widely recognized heritability estimates.

AB - Monozygotic (MZ) and dizygotic (DZ) twins participate in research that partitions variance in health, disease, and behavior into genetic and environmental components. However, there are other innovative roles for twins in medical research. One such way is involving MZ and/or DZ twins in co-twin control-designed randomized controlled trials (RCTs). To our knowledge, no reviews have been conducted that summarizes the involvement of twins in RCTs. Therefore, we conducted a systematic literature search using the U.S. Clinical Trials Database, NHS electronic databases, MEDLINE, EMBASE, and PsychINFO for RCTs on publications involving MZ and/or DZ twins as RCT participants. Out of the 186,027 clinical trials registered in the U.S. clinical trial register ClinicaTrails.gov, only six RCTs used twins as participants. From 1,598 articles identified in our search, 50 peer-reviewed English language publications met our pre-defined inclusion criteria. Sample sizes for RCTs have ranged from a total number of participants from 2 to 1,162; however, 32 (64%) studies had a sample size of 100 or less, and of those, 12 (24%) had fewer than 10. Both MZ and DZ twins have been recruited to the RCTs. In most instances (33/50) each twin from a pair were assigned to different study arms. Most of those studies included MZ twins only. Despite the methodological advantages, the use of MZ and DZ twins as participants in interventional RCTs appeared limited. The continuous development of innovative twin designs, especially RCTs, indicates that twin research can extend beyond the more widely recognized heritability estimates.

KW - RCT

KW - randomization

KW - sample size

KW - twin research

UR - http://www.scopus.com/inward/record.url?scp=85042223554&partnerID=8YFLogxK

U2 - 10.1017/thg.2017.67

DO - 10.1017/thg.2017.67

M3 - Article

VL - 21

SP - 51

EP - 56

JO - Twin Research and Human Genetics

JF - Twin Research and Human Genetics

SN - 1832-4274

IS - 1

ER -

Sumathipala A, Yelland L, Green D, Shepherd T, Jayaweera K, Ferreira P et al. Twins as Participants in Randomized Controlled Trials: A Review of Published Literature. Twin Research and Human Genetics. 2018 Feb 1;21(1):51-56. https://doi.org/10.1017/thg.2017.67